Analysis of the role of adjuvant chemotherapy for invasive carcinoma of the esophagus

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 23, Issue 6, 2000, Pages 554-558

  Jani, Ashesh B ^a,b   Connell, Philip P ^a   Vesich, Valerie J ^a   O'Brien, Katherine M ^a   Chen, Luci M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Carcinoma; Chemotherapy; Esophagus; Radio therapy; Retrospective analysis; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; HYDROXYUREA;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURVIVAL; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SURVIVAL ANALYSIS;

EID: 0034442107     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200012000-00003     Document Type: Article

References (41)

1. Esophageal cancers: Changing character, increasing incidence
2. Principles of surgical treatment for carcinoma of the esophagus: Analysis of lymph node involvement
3. Treatment of carcinoma of the esophagus or cardia
4. En bloc esophagectomy: The first 100 patients
5. Abdominocervical (transhiatal) oesophagectomy in the management of oesophageal carcinoma
6. Left-sided subtotal oesophagectomy for carcinoma
7. Adenocarcinoma of the distal esophagus and gastric cardia
8. Oesophageal squamous cell carcinoma: I. A critical review of surgery
9. Carcinoma of the esophagus: Sites of failure
10. Carcinoma of the esophagus: Pretreatment assessment, correlation of radiation treatment parameters with survival, and identification and management of radiation treatment failure
11. Adenocarcinoma of the esophagus and esophago-gastric junction: The effects of single and combined modalities on the survival and patterns of failure following treatment
12. High-dose-rate intraluminal brachytherapy for esophageal cancer: 10 Years experience in Hyogo College of Medicine
13. Preoperative radiation therapy for carcinoma of the esophagus
14. The value of preoperative radiotherapy in esophageal cancer: Results of a study of the EORTC
15. Preoperative radiotherapy in esophageal carcinoma: A meta-analysis using individual patient data (oesophageal cancer collaborative group)
16. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial
17. Current status of new drugs and multidisciplinary approaches in patients with carcinoma of the esophagus
18. Carcinoma of the esophagus. Part 2: Adjuvant therapy
19. Chemotherapy for carcinoma of the esophagus: A comparison of evidence from meta-analyses of randomized trials and of historical control studies
20. Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction
21. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus
22. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer
23. Combined modality therapy in non-small lung cancer and esophageal cancer: A phase I dose-escalation study of docetaxel with concurrent radiotherapy
24. Long-term results of infusional 5-FU, mitomycin-c, and radiation as primary management of esophageal carcinoma
25. Combined chemotherapy and radiotherapy composed with radiotherapy alone in patients with cancer of the esophagus
26. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study
27. Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037)
28. Pre-operative sequential chemo and radiochemotherapy in locally advanced carcinomas of the lower oesophagus and gastro-oesophageal junction
29. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: Final report
30. Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus
31. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus
32. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma
33. Final report of Intergroup Trial 0122 (ECOG PE289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus
34. Chemotherapeutic and biologic radiation enhancement
35. Biologic rationale of combined radiotherapy and chemotherapy
36. Surgical implications for infusion chemotherapy
37. Accelerated hyperfractionated radiation therapy and concurrent 5-fluorouracil/cisplatin chemotherapy for locoregional squamous cell carcinoma of the thoracic esophagus: A phase II study
38. Continuous hyperfractionated accelerated radiotherapy (CHART) in localized cancer of the esophagus
39. Neoadjuvant chemotherapy and hyperfractionated radiotherapy with concurrent low-dose chemotherapy for squamous cell esophageal carcinoma
40. Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for stages IIB and III esophageal carcinoma: Results of a pilot study
41. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma